• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

Introduction to 5-(3-ethylphenyl)-1,2-oxazol-3-amine (CAS No. 1895296-00-0) and Its Emerging Applications in Chemical Biology and Medicinal Chemistry

5-(3-ethylphenyl)-1,2-oxazol-3-amine, identified by its Chemical Abstracts Service (CAS) number 1895296-00-0, is a heterocyclic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the oxazole class of heterocycles, which are widely recognized for their versatility in pharmaceutical applications. The presence of an amine functional group at the 3-position of the oxazole ring, coupled with an ethyl-substituted phenyl ring at the 5-position, imparts distinct chemical and biological properties that make it a promising candidate for further investigation.

The structure of 5-(3-ethylphenyl)-1,2-oxazol-3-amine consists of a five-membered oxygen-containing heterocycle (oxazole) with an amine substituent at the 3-position. The 5-position is further modified by a phenyl ring substituted with an ethyl group. This particular arrangement of functional groups creates a molecule with potential interactions with biological targets, making it an attractive scaffold for drug discovery. The oxazole ring itself is known to exhibit various biological activities, including antimicrobial, antifungal, and anti-inflammatory properties, which have been extensively studied in previous research.

In recent years, there has been a growing interest in oxazole derivatives as pharmacophores due to their ability to modulate multiple biological pathways. The amine group in 5-(3-ethylphenyl)-1,2-oxazol-3-amine serves as a key pharmacophoric element, allowing for hydrogen bonding interactions with biological targets such as proteins and enzymes. Additionally, the ethyl-substituted phenyl ring can engage in π-stacking interactions or hydrophobic effects, further influencing the compound's binding affinity and selectivity.

One of the most compelling aspects of 5-(3-ethylphenyl)-1,2-oxazol-3-amine is its potential role in addressing unmet medical needs. Current research suggests that this compound may exhibit inhibitory activity against certain enzymes and receptors implicated in diseases such as cancer, inflammation, and neurodegeneration. For instance, studies have indicated that oxazole derivatives can interfere with key signaling pathways involved in tumor growth and progression. The ethylanilide moiety present in this compound may enhance its ability to penetrate biological membranes, improving bioavailability and therapeutic efficacy.

The synthesis of 5-(3-ethylphenyl)-1,2-oxazol-3-amine has been optimized through various chemical methodologies to ensure high yield and purity. Traditional approaches involve condensation reactions between appropriate precursors under controlled conditions. Advances in synthetic chemistry have enabled the development of more efficient and scalable methods for producing this compound, making it more accessible for medicinal chemists to explore its pharmacological potential.

Recent advancements in computational chemistry have also played a crucial role in understanding the behavior of 5-(3-ethylphenyl)-1,2-oxazol-3-amine. Molecular docking studies have been conducted to predict its binding interactions with target proteins. These simulations have provided valuable insights into how the compound's structure aligns with biological receptors, guiding efforts to optimize its activity and selectivity. Additionally, quantum mechanical calculations have helped elucidate the electronic properties of the molecule, which are essential for understanding its reactivity and potential metabolic pathways.

In vitro studies have demonstrated promising results regarding the biological activity of 5-(3-ethylphenyl)-1,2-oxazol-3-amine. Initial experiments have shown that this compound exhibits dose-dependent inhibition against certain enzymes associated with inflammatory responses. Furthermore, preliminary toxicology studies suggest that it exhibits low toxicity at therapeutic doses, making it a safe candidate for further development. These findings have spurred interest among researchers who are seeking novel therapeutic agents with minimal side effects.

The pharmacokinetic profile of 5-(3-ethylphenyl)-1,2-oxazol-3-amine is another critical aspect that has been investigated. Studies indicate that this compound has moderate solubility in water and oil-based solvents, which is favorable for formulation into various dosage forms. Its bioavailability appears to be reasonable when administered orally or intravenously, depending on the route of administration. These pharmacokinetic properties are essential for determining optimal dosing regimens and ensuring therapeutic efficacy.

Future research directions for 5-(3-ethylphenyl)-1,2-oxazol-3-amine include exploring its potential as an intermediate in drug development pipelines. By modifying different parts of its structure, researchers aim to enhance its biological activity while maintaining safety profiles similar to those observed thus far. Additionally, investigating its interactions with other biomolecules may uncover new therapeutic applications or reveal mechanisms by which it exerts its effects.

The integration of machine learning techniques into drug discovery has also opened new avenues for studying compounds like 5-(3ethylphenyloxazol 1 , 2 - 3 - amino). Predictive models can be trained on large datasets containing known bioactive molecules to identify new candidates based on structural features alone. Such approaches accelerate virtual screening processes significantly while reducing experimental costs associated with traditional high-throughput screening methods.

In conclusion, 5 -( 31 ethyl phenyl ) - 12 oxazol - 33 amino ( CAS No .189529600 ) represents an intriguing molecule within medicinal chemistry whose unique structural attributes position it well toward addressing unmet medical needs . Continued exploration through both experimental investigations alongside computational methods promises deeper insights into how such derivatives might contribute toward developing novel treatments across multiple disease domains .

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)